Search Results - Katus HA

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy by Helmschrott M, Rivinius R, Bruckner T, Katus HA, Doesch AO

Connect to this object online.

A comparative study on endovascular treatment of (sub)acute critical limb ischemia: mechanical thrombectomy vs thrombolysis by Kronlage M, Printz I, Vogel B, Blessing E, Müller OJ, Katus HA, Erbel C

Connect to this object online.

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation by Rivinius R, Helmschrott M, Ruhparwar A, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO

Connect to this object online.

Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action by Vonderlin N, Fischer F, Zitron E, Seyler C, Scherer D, Thomas D, Katus HA, Scholz EP

Connect to this object online.

Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action by Vonderlin N, Fischer F, Zitron E, Seyler C, Scherer D, Thomas D, Katus HA, Scholz EP

Connect to this object online.

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study by Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA

Connect to this object online.

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation by Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA

Connect to this object online.

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions by Akhavanpoor M, Gleissner CA, Gorbatsch S, Doesch AO, Akhavanpoor H, Wangler S, Jahn F, Lasitschka F, Katus HA, Erbel C

Connect to this object online.

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis by Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR

Connect to this object online.

Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study by aus dem Siepen F, Bauer R, Aurich M, Buss SJ, Steen H, Altl, K, Katus HA, Kristen AV

Connect to this object online.

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality by Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO

Connect to this object online.

The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation by Rivinius R, Helmschrott M, Ruhparwar A, Erbel C, Gleissner CA, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO

Connect to this object online.

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation by Kraeuter M, Helmschrott M, Erbel C, Gleissner CA, Frankenstein L, Schmack B, Ruhparwar A, Ehlermann P, Katus HA, Doesch AO

Connect to this object online.

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions by Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, Hakimi M, Dengler TJ, Katus HA, Erbel C

Connect to this object online.

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis by Preusch MR, Rusnak J, Staudacher K, Mogler C, Uhlmann L, Sievers P, Bea F, Katus HA, Blessing E, Staudacher I

Connect to this object online.

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation by Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleissner C, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA, Doesch AO

Connect to this object online.

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation by Helmschrott M, Rivinius R, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Ehlermann P, Bruckner T, Katus HA, Doesch AO

Connect to this object online.

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen by Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO

Connect to this object online.

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients by Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA

Connect to this object online.

Trigger-Specific Remodeling of KCa2 Potassium Channels in Models of Atrial Fibrillation by Rahm AK, Gramlich D, Wieder T, Müller ME, Schoeffel A, El Tahry FA, Most P, Heimberger T, Sandke S, Weis T, Ullrich ND, Korff T, Lugenbiel P, Katus HA, Thomas D

Connect to this object online.